-
平臺編號：bio-49862
-
國際編號：ATCC VR-1003
-
拉丁屬名： Human poliovirus 2
-
規(guī)格：frozen
-
用途：ATCC原裝進口
-
服務(wù)費用：
加載中…… - 訂購
-
注意事項：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
Human poliovirus 2
ATCC? Number:VR-1003?
Classification: Picornaviridae, Enterovirus, Poliovirus
Agent: Human poliovirus 2 deposited as Poliovirus 2
Strain: P-712
Depositors: NIH/NIAID
Biosafety Level:3
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : monkey kidney cells primates; primate cells
Effect : Yes, in vitro effects: Cytopathic effect in tissue culture
Comments : [The BMBL notes that all laboratory personnel working directly with the agent must have documented polio vaccination or demonstrated serologic evidence of immunity to all three poliovirus types. (CDC/NIH Biosafety in Microbiological and Biomedical Laboratories, 4th ed, 1999 - stock no. 017-040-00547-4)]. *) Requests for this agent must carry signed statement assuming all risks and responsibility for lab handling.
Related Products: antiserum:ATCC VR-1003AS/HOalso distributed as:ATCC VR-61
Classification: Picornaviridae, Enterovirus, Poliovirus
Agent: Human poliovirus 2 deposited as Poliovirus 2
Strain: P-712
Depositors: NIH/NIAID
Biosafety Level:3
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : monkey kidney cells primates; primate cells
Effect : Yes, in vitro effects: Cytopathic effect in tissue culture
Comments : [The BMBL notes that all laboratory personnel working directly with the agent must have documented polio vaccination or demonstrated serologic evidence of immunity to all three poliovirus types. (CDC/NIH Biosafety in Microbiological and Biomedical Laboratories, 4th ed, 1999 - stock no. 017-040-00547-4)]. *) Requests for this agent must carry signed statement assuming all risks and responsibility for lab handling.
Related Products: antiserum:ATCC VR-1003AS/HOalso distributed as:ATCC VR-61
